Qinghai Lin

408 total citations
14 papers, 280 citations indexed

About

Qinghai Lin is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Qinghai Lin has authored 14 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Qinghai Lin's work include RNA modifications and cancer (5 papers), Cancer-related gene regulation (3 papers) and Epigenetics and DNA Methylation (2 papers). Qinghai Lin is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related gene regulation (3 papers) and Epigenetics and DNA Methylation (2 papers). Qinghai Lin collaborates with scholars based in China and Sweden. Qinghai Lin's co-authors include Lifen Gao, Xiaohong Liang, Chunhong Ma, Xiaojia Song, Zehua Wang, Lisheng Liu, Zhuanchang Wu, Tixiao Wang, Leiqi Xu and Yankun Zhang and has published in prestigious journals such as The Journal of Immunology, Journal of Leukocyte Biology and The Journal of Pathology.

In The Last Decade

Qinghai Lin

13 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qinghai Lin China 9 195 94 65 32 32 14 280
Banglun Pan China 10 153 0.8× 102 1.1× 91 1.4× 73 2.3× 30 0.9× 24 270
Cherlie Lot Sum Yeung Hong Kong 7 186 1.0× 143 1.5× 59 0.9× 36 1.1× 23 0.7× 11 270
Xiwu Ouyang China 12 247 1.3× 173 1.8× 44 0.7× 37 1.2× 23 0.7× 16 321
Ruizhi Wang China 6 279 1.4× 239 2.5× 42 0.6× 46 1.4× 40 1.3× 19 390
Robert Habib United Kingdom 5 158 0.8× 70 0.7× 37 0.6× 22 0.7× 20 0.6× 12 225
Muhammad Yogi Pratama Indonesia 11 206 1.1× 181 1.9× 22 0.3× 30 0.9× 40 1.3× 24 318
Dawei Zou United States 10 106 0.5× 56 0.6× 128 2.0× 73 2.3× 22 0.7× 22 280
Qijing Wang China 10 140 0.7× 53 0.6× 56 0.9× 70 2.2× 20 0.6× 11 217
Huixing Huang China 6 163 0.8× 116 1.2× 21 0.3× 36 1.1× 42 1.3× 8 241

Countries citing papers authored by Qinghai Lin

Since Specialization
Citations

This map shows the geographic impact of Qinghai Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinghai Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinghai Lin more than expected).

Fields of papers citing papers by Qinghai Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinghai Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinghai Lin. The network helps show where Qinghai Lin may publish in the future.

Co-authorship network of co-authors of Qinghai Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Qinghai Lin. A scholar is included among the top collaborators of Qinghai Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinghai Lin. Qinghai Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wu, Yongkang, et al.. (2025). Retrospective study: the value of GDF-15 and conventional markers in combination for clinical diagnosis of lung cancer. PeerJ. 13. e20281–e20281. 1 indexed citations
3.
Fan, Yu‐Chen, Zehua Wang, Mengzhen Li, et al.. (2024). Probiotics and their metabolite spermidine enhance IFN-γ+CD4+ T cell immunity to inhibit hepatitis B virus. Cell Reports Medicine. 5(11). 101822–101822. 5 indexed citations
4.
Zhang, Zhenyu, Jing Kong, R. Ma, et al.. (2024). Hypothesis paper: GDF15 demonstrated promising potential in Cancer diagnosis and correlated with cardiac biomarkers. Cardio-Oncology. 10(1). 56–56. 1 indexed citations
5.
Wang, Shiwen, Xingguo Song, Kangyu Wang, et al.. (2022). Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer. Frontiers in Oncology. 12. 986343–986343. 17 indexed citations
6.
Wang, Shunchao, et al.. (2022). Exploring the Role of Attitudinal Factors in Electric Vehicle Timeshare Rentals Adoption. Applied Sciences. 13(1). 12–12. 8 indexed citations
7.
Liu, Lisheng, et al.. (2021). Histone demethylase KDM2A: Biological functions and clinical values (Review). Experimental and Therapeutic Medicine. 22(1). 723–723. 32 indexed citations
8.
Lin, Qinghai, Zhuanchang Wu, Xuetian Yue, et al.. (2020). ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation. EBioMedicine. 53. 102676–102676. 49 indexed citations
9.
Wang, Zehua, Liang Kong, Siyu Tan, et al.. (2020). Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3. The Journal of Immunology. 204(8). 2232–2241. 47 indexed citations
10.
Lin, Qinghai, Zhuanchang Wu, Yankun Zhang, et al.. (2020). ZHX2 inhibits SREBP1c‐mediated de novo lipogenesis in hepatocellular carcinoma via miR‐24‐3p. The Journal of Pathology. 252(4). 358–370. 35 indexed citations
11.
Lin, Qinghai, et al.. (2018). PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR. Cancer Biotherapy and Radiopharmaceuticals. 33(2). 60–64. 15 indexed citations
12.
Xu, Leiqi, Zhuanchang Wu, Zehua Wang, et al.. (2018). Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners. Antiviral Research. 153. 114–123. 24 indexed citations
13.
Zhao, Di, Min Guo, Bing Liu, et al.. (2017). Frontline Science: Tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE. Journal of Leukocyte Biology. 102(6). 1313–1322. 31 indexed citations
14.
Lin, Qinghai, et al.. (2015). ERGIC3, which is regulated by miR‐203a, is a potential biomarker for non‐small cell lung cancer. Cancer Science. 106(10). 1463–1473. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026